UCSF Interstitial Lung Disease Program — San Francisco, California

UCSF Interstitial Lung Disease Program is a clinical research site located in San Francisco, California, United States 94143.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCSF Interstitial Lung Disease Program has participated in 1 clinical trials.

Therapeutic areas: Idiopathic Pulmonary Fibrosis.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCSF Interstitial Lung Disease Program?

UCSF Interstitial Lung Disease Program has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCSF Interstitial Lung Disease Program conducted?

UCSF Interstitial Lung Disease Program has 1 clinical trials on record. Their work covers Idiopathic Pulmonary Fibrosis.

Is UCSF Interstitial Lung Disease Program accredited by Crixeo Health?

UCSF Interstitial Lung Disease Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCSF Interstitial Lung Disease Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.